Breast Cancer
CARP-1 is a novel regulator of retinoids that diminish cancer
Published in Gene Therapy Weekly, October 16th, 2003
"CD437, a novel retinoid, causes cell cycle arrest and apoptosis in a number of cancer cells including human breast carcinoma (HBC) by utilizing an undefined retinoic acid receptor/retinoid X receptor-independent mechanism. To delineate mediators of CD437 signaling, we utilized a random antisense-dependent functional knockout genetic approach. We identified a cDNA that encodes approximately 130- kDa HBC cell perinuclear protein (termed CARP-1)," scientists in the United States report.
"Treatments with CD437 or chemotherapeutic agent adriamycin, as well as serum deprivation of HBC cells,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2003-10-16)
More Articles from Gene Therapy Weekly
- Head and Neck Cancer
Liposomal conjugation improves adenoviral transduction of squamous cell cancer - Oncology
Nonradioactive iodide stimulates apoptosis in genetically modified cancer cells - Endocrinology
Excess Bcl-2 production reverses programmed cell death in beta cells - Neuroscience
Gene-modified cells correct Parkinson-like disease in animal models - Oncology
Gene expression mechanisms enhance magnetic resonance images of prostate cancer - Orthopedics
Bone morphogenetic protein-4 gene therapy regenerates in vivo bone formation - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
